pituitary adenylate cyclase activating polypeptide (pAcAp) is a regulatory and cytoprotective neuropeptide, its deficiency implies accelerated aging in mice. It is present in the auditory system having antiapoptotic effects. Expression of Ca 2+ -binding proteins and its PAC1 receptor differs in the inner ear of PACAP-deficient (KO) and wild-type (WT) mice. Our aim was to elucidate the functional role of PACAP in the auditory system. Auditory brainstem response (ABR) tests found higher hearing thresholds in KO mice at click and low frequency burst stimuli. Hearing impairment at higher frequencies showed as reduced ABR wave amplitudes and latencies in KO animals. Increase in neuronal activity, demonstrated by c-Fos immunolabeling, was lower in KO mice after noise exposure in the ventral and dorsal cochlear nuclei. Noise induced neuronal activation was similar in further relay nuclei of the auditory pathway of WT and KO mice. Based on the similar inflammatory and angiogenic protein profile data from cochlear duct lysates, neither inflammation nor disturbed angiogenesis, as potential pathological components in sensorineural hearing losses, seem to be involved in the pathomechanism of the presented functional and morphological changes in PACAP KO mice. The hearing impairment is probably concomitant with the markedly accelerated aging processes in these animals.
Results
In vivo ABR recordings -Hearing thresholds. PACAP KO mice had significantly higher hearing thresholds at click and at low frequency burst stimuli -4.1 kHz and 8.2 kHz -at the age of 1.5 months ( Fig. 1, Table 1 ). This represents a massive hearing deficit in PACAP KO mice compared to the WT animals. We repeated the ABR measurements at the age of 4 and 8 months ( Fig. 1/b , Table 1 ). The auditory thresholds were further elevated at lower frequencies in older PACAP KO mice, however, the WT mice also reached a plateau with aging. Therefore, the difference between the two groups was less pronounced ( Fig. 1/b , Table 1 ). At higher frequencies, we did not find differences in the hearing thresholds between the two groups at either age.
In vivo ABR recordings -Analysis of peak amplitudes and latencies. We analysed the ABR wave amplitudes and latencies in 1.5-month-old mice at all measured stimulus intensity levels to explore further differences between the PACAP KO and WT mice at higher frequencies (16.4, 32.8 and 65.6 kHz) where there were no differences in the hearing thresholds (Figs 2, 3) . All WT and PACAP KO mice were analysed, but not all 5 peaks appeared at each frequency at each sound pressure level [e.g. peak I at 16 .4 kHz presented only in one WT mice at 30 dB sound pressure level (SPL), while in 29 WT mice at 90 dB SPL]. There was a significant decrease in the ABR peak amplitudes of PACAP KO mice on peaks I-II and IV-V at high stimulus intensity (Fig. 2 , for P values please see Supplementary Table S1 ). The latencies were also tendentially shorter at high frequencies in all peaks and the differences were significant in several cases ( Fig. 3 , for P values please see Supplementary Table S1 ). Differences are easily recognizable visually on the superimposed average curves of ABR waves of the PACAP KO and WT mice at 32.8 and 65.6 kHz (Figs 2/c and 3/c). We often observed the fusion of peaks III and IV in both WT and PACAP KO animals. However, this merge occurred more frequently in PACAP KO mice, as it is shown by the lower incidence of peak IV in these mice at 16 .4, 32.8 and 65.6 kHz at higher stimulus intensities ( Fig. 4 , Supplementary Table S1 ).
Auditory pathway activation and cell count measurement -c-Fos immunolabeling, Nissl staining.
We examined the neuronal activation with c-Fos immunoreactivity in the auditory pathway (Figs 5, 6, Table 2 ). In the ventral cochlear nucleus (VCN), there was almost no cell activation in mice, which were held in a silent environment for 24 hours before termination (labelled as 'silent'). There was a significant elevation of activated neurons in both WT and PACAP KO animals after exposure to half an hour filtered white noise. The elevation was significantly smaller in KO animals compared to WT ones ( Fig. 5 /a,b, Table 2 ). We found similar results in the dorsal cochlear nucleus (DCN) with almost no cell activation in the silent environment and significant elevation in the number of activated neurons after noise application both in WT and PACAP KO animals. The elevation was significantly smaller in KO animals compared to WT animals ( Fig. 5 /a,c, Table 2 ). We applied Nissl staining to the slides of VCN and DCN of WT and PACAP KO animals to decide whether a decreased number of Hearing threshold at 20 dB sound pressure in WT (black arrow) and at 60 dB sound pressure in KO mice (red arrow). ABR peaks I-V labelled at 80 dB WT curve: peak I arising from the cochlea/spiral ganglion neurons, peaks II-V arising from upper nuclei of the auditory pathway. (b) Hearing thresholds in WT and KO mice with click stimuli and at different frequencies at the age of 1.5, 4 and 8 months. Asterisks indicate significant differences between KO and WT mice. Mean ± SEM, 2-way-ANOVA, Bonferroni post-hoc test. ****p < 0.0001, **p < 0.01, *p < 0.05 vs. WT values at the corresponding stimulus frequency.
The differences between the WT and KO animals disappeared in the central parts of the auditory pathway ( Fig. 6 ). There was a small neuronal activation in the silent group regarding the medial superior olive (MSO) and lateral superior olive (LSO) parts of the superior olivary complex (SOC) in both WT and PACAP KO animals. We found significant elevation of c-Fos immunolabeling in both WT and PACAP KO animals after noise application but there was no significant difference between the WT and PACAP KO groups ( Fig. 6 /a, Table 2 ). We also measured the number of activated cells in the region of ventromedial and ventrolateral periolivary nuclei (VMPN and VLPN, respectively) with similar results. Noise application resulted in an elevation of activated neurons in both WT and PACAP KO animals but there was no difference between the WT and PACAP KO groups ( Fig. 6 /a, Table 2 ). The nuclei of the lateral lemniscus (NLL) yielded similar results: we measured neuronal activation in the silent animal groups that was significantly elevated after noise application but there was no difference between the WT and PACAP KO groups ( Fig. 6 /b, Table 2 ). We also found in the inferior colliculus (IC) a baseline cell activation in silent animal groups which elevated significantly after noise application again with no difference between the WT and PACAP KO groups ( Fig. 6 /c, Table 2 ). In the primary auditory cortex, the neuronal activation in the silent animal groups showed a tendency to be elevated after noise application but this elevation was not significant. There was no significant difference between the WT and PACAP KO animals ( Fig. 6/d , Table 2 ). Without significant differences in the number of activated neurons, we did not perform Nissl staining in these nuclei.
Cochlear duct proteome profile analysis. We used Proteome Profilers from the R&D Systems to elucidate the protein composition of the cochlear ducts of WT and PACAP KO mice (Figs 7, 8) . The Mouse Cytokine Array Panel A and the Mouse Angiogenesis Array Kits are eligible to detect 40 and 53 different proteins, respectively. From the lysates of cochlear ducts endostatin, acidic FGF, osteopontin, BLC, CD54, PF4, TF, DPPIV, IGFBP-2, Serpin F1 and CXCL12 were in detectable quantity. The pixel density of the respective spots did not show significant differences between the WT and PACAP KO groups ( Fig. 8 , Supplementary Table S2 ).
Discussion
Hearing impairment is a disease affecting approximately 500 million people worldwide. Hearing loss could be of various origins, including genetic disorders, intrauterine damage, contagious diseases, noise trauma, aging or toxic agents 44 . After our earlier studies in the inner ear, our present study further elucidates the role of endogenous PACAP in the auditory pathway and could lead to further investigations on the use of PACAP in different auditory system deficiencies.
The presence of PACAP has been demonstrated in the nuclei of the auditory pathway. It is present in the cell bodies and fibres of cochlear nuclei, with higher expression in the VCN 21, 22 . It has been found in different nuclei of the SOC in rat and Djungarian hamsters, being described in the perikarya of medial nucleus of the trapezoid body, MSO, LSO and periolivary nuclei, including the nuclei of the olivocochlear fibres which could be the source of PACAP positive fibres in the cochlea 22, 45 . PACAP was found in the medial olivocochlear tract ending on the outer hair cells but not in the lateral olivocochlear tract, which terminates on the dendrites of the spiral ganglion neurons under the inner hair cells. This confirms the theory that PACAP has a greater role in the efferent than in the afferent innervation of the cochlea 19 . PACAP was also found in the IC and medial geniculate body in rat and human brains 21, 46 . PAC1 receptor mRNA expression was found in VCN, DCN, SOC, NLL, IC and medial geniculate body in the rat brain [47] [48] [49] . Human studies showed no PAC1 receptor expression in the IC under normal circumstances but its weak expression was present in sudden infant death syndrome brain samples 50 .
Based on these results, we examined the changes of the hearing function in PACAP KO animals. We found with ABR hearing threshold tests that PACAP KO mice have a significantly worse hearing with click stimuli and at 4.1 and 8.2 kHz frequencies compared to the WT ones at 1.5 and 4 months of age but there are no differences in the hearing thresholds at higher frequencies. At 8 months of age, the difference was significant at click and 4.1 kHz burst stimuli. With the evaluation of the hearing thresholds, it has to be taken into account that the CD1 mouse strain is subject to age related hearing loss. The hearing threshold pattern found in our experiments coincides with earlier described patterns characteristic for CD1 mice 51 . This could be the reason that there is no difference in the hearing threshold at higher frequencies and cause the disappearance of the significance at 8.2 kHz between the PACAP KO and WT mice at the age of 8 months. Although PACAP KO animals have no obvious deficit in hearing thresholds compared to WT animals in the higher frequency range tested (16.4; 32.8 and 65.6 kHz), amplitude and latency examinations revealed altered hearing functions at these frequencies. The amplitudes -in www.nature.com/scientificreports www.nature.com/scientificreports/ line with the activation and firing of the neurons in the hearing pathway -of the PACAP KO mice showed a strong decrease compared to WT littermates. However, the latencies -the time of the response after the stimulus -of the PACAP-deficient mice showed a bit faster neuronal activation and transmission. Decreased amplitude and latency values are probably the subtle indications of hearing impairment not revealed by hearing threshold measurements 52, 53 . During the analysis of individual waves, the labelling of the peaks of PACAP-deficient mice was often cumbersome because of peak fusions. In KO mice, we saw fusion of peaks III and IV, however, these ABR waves in WT animals were rather separated.
To confirm the functional findings, we performed c-Fos immunolabeling to show the neuronal activation of the nuclei of the auditory pathway. Unlike Fos-B, c-Fos is a short-term activation marker of nerve cells commonly used in the auditory pathway resulting in alterations at gene expression level 54, 55 . The activation was achieved by applying 4 to 20 kHz noise with 100 dB sound pressure for half an hour for the mice. Several different setups could be used for c-Fos activation measurements in the auditory pathway 56, 57 , however, in our model we allowed 1 hour for the expression and nuclear translocation of c-Fos.
In the VCN and DCN, we found very few c-Fos immunopositive cells in the silent environment in both groups. However, there were activated neurons both in the WT and PACAP KO animals after noise exposure but the activation was significantly smaller in the KO mice. These results correspond to the functional ABR findings. Regarding the central parts of the auditory pathway, there was baseline cell activation in the SOC, NLL, IC and primary auditory cortex (AU1). The number of activated cells was significantly elevated after noise exposure www.nature.com/scientificreports www.nature.com/scientificreports/ in the SOC, NLL and IC in both genotype groups and elevation was also detected in the AU1 region but it was non-significant. However, we did not find any difference between the WT and PACAP KO groups. The significant differences between the silent and noise-exposed groups show that our measurements are valid and the lack of difference between the two genotypes does not result from a technical error. The reason for the baseline activation of neurons could arise from the fact that these nuclei are not simply relay stations of the auditory pathway but that they obtain afferentation from other brain areas and serve more complex functions. SOC receives innervation from IC, from thalamus, from AU1 and from serotonergic and noradrenergic centres; NLL from IC 58, 59 . IC gains information from auditory and somatosensory cortices and from the somatosensory nuclei of the brainstem 60 . AU1 has a leading role in multimodal information processing 61 . These connections can explain the baseline neuronal activity in the silent animal groups and the disappearance of the differences between the WT and KO animal groups. It has long been hypothesized that changes in other signalling pathways could play a role in compensating for the lack of PACAP in PACAP-deficient animals 34, 62 . We assume that there is a greater possibility for this compensation in the central nuclei of the auditory pathway as those obtain more complex connection patterns with several neuronal types releasing numerous neurotransmitters in these areas.
To elucidate the cause of the impaired hearing functions we aimed to further explore the role of endogenous PACAP in the inner ear, and therefore we performed proteome profile analysis from cochlear duct lysates from WT and PACAP-deficient mice. As mentioned in the introduction, PACAP and its specific PAC1 receptor have www.nature.com/scientificreports www.nature.com/scientificreports/ been demonstrated earlier in several parts of the inner ear 16 . After showing that PACAP had antiapoptotic effects on inner ear cells in vitro 23 , our research group also demonstrated that the levels of Ca 2+ -binding proteins (parvalbumin, calretinin, calbindin) are elevated in the hair cells of PACAP KO animals compared to WT ones 17 . We also described elevated Ca 2+ -binding protein levels in WT animals after ototoxic kanamycin treatment 43 . We suppose that the elevation of Ca 2+ -binding proteins in PACAP KO animals under normal circumstances could be a compensatory mechanism indicating pathological conditions in the inner ear. This pathology could be the result of the missing antiapoptotic and oxidative stress attenuating effects of PACAP in these animals. However, the baseline elevated Ca 2+ -binding protein levels in PACAP KO animals did not increase further after kanamycin treatment possibly indicating a limitation of this compensatory mechanism. Inflammation 63,64 and angiogenesis 65 are known processes involved in different types of sensorineural hearing loss. In this study, we investigated their role in hearing loss that developed in the absence of endogenous PACAP. The use of isolated cochlear duct lysates excludes the contamination by proteins from the bony cochlea. We detected the ubiquitous cell surface enzyme DPPIV, antiapoptotic osteopontin, intercellular adhesion molecule CD54 and several other proteins taking part in angiogenic (acidic FGF, CXCL12), antiangiogenic (endostatin, Serpin F1), chemotactic (BLC, PF4, CXCL12) and coagulation (PF4, TF) procedures in both WT and PACAP-deficient mice. However, we did not find significant differences in the expression of the measured proteins between the two genotypes. We concluded that the differences in hearing between the WT and PACAP KO mice cannot be substantiated by alterations in the expression of the investigated proteins in the endolymphatic ducts. Results of the chosen proteome profiler kits do not support the involvement of inflammatory or angiogenic processes in the hearing impairment caused by the lack of PACAP.
It still remains an open question whether the hearing loss is caused by inner ear or auditory pathway lesions. It is known that isolated inner ear lesions also lead to complex changes in the auditory pathway. Besides the direct effect of the absence of neuronal activation in the nuclei of the auditory pathway, it could also lead to alterations in the tyrosine hydroxylase or Ca 2+ -binding protein expression 66, 67 . The lesion of the inner ear alone could be the reason of the impaired hearing function and attenuated c-Fos expression in PACAP KO animals. Nissl staining also confirmed this, whereby in spite of the smaller number of activated c-Fos expressing neurons, the cell number of neurons in the VCN and DCN did not change significantly in PACAP KO animals compared to the WT ones.
We confirmed that CD1 mice have a progressive hearing loss by aging. This process involves the loss of inner and outer hair cells in the inner ear 51 . It is also known that aging processes are accelerated in PACAP KO mice affecting several organ systems 14, 25, [39] [40] [41] . An acceptable hypothesis could be that the changes we found in the auditory system of the PACAP KO mice are the result of the accelerated aging of the inner ear and auditory pathway. The neuroprotective and general cytoprotective effects of PACAP are not present in PACAP KO animals that could be the cause for an increased hair cell loss and consequent impaired hearing functions. However, hearing loss and the accompanying hair cell damage is present in the WT CD1 animals 51 , it could be only more expressively present in KO mice. This could be the reason why we did not detect significant differences in the proteome profile of WT and PACAP KO mice.
We conclude that endogenous PACAP is essential for normal hearing functions. The normal aging and the processes of hearing loss in the inner ear are accelerated in PACAP-deficient mice, but the exact mechanisms are yet to be elucidated. Still, the possibility arises that administration of PACAP or an agonist of its receptors may have a curative effect in age-related or noise-/ototoxic-drug-induced hearing loss, as we have already shown PACAP protection in another sensory system 13, 68 . Therefore, we plan to elucidate the effects of ototoxic insults in PACAP KO animals and examine whether the impairments could be prevented by exogenous PACAP/agonist administration bringing us one step closer to reveal the curative effects of PACAP.
Materials and Methods
Animals. All 
In vivo recordings of auditory brainstem responses (ABRs).
In mice and humans alike, sound-evoked potentials from the auditory brainstem appear as a series of consecutive peaks and valleys of ABR waves. These peaks come from the synchronous synaptic activity of nuclei along the afferent auditory pathway ( Fig. 1/a) . The first peak arises from the cochlea / spiral ganglion neurons ~1 ms after the stimulus onset (latency). Peaks II-V arise from the upper nuclei (i.e. cochlear nuclei, medial nucleus of the trapezoid body, SOC and IC) of the auditory pathway 69 . ABR measurements were performed as described before 70 . Briefly: mice were anaesthetized by intraperitoneal (i.p.) injections of ketamine (100 mg/kg, CP-Ketamin 10% injection, Produlab Pharma B.V., Netherland) and xylazine (10 mg/kg, CP-Xylazine 2% injection, Produlab Pharma B.V., Netherland). Ketamine-xylazine affects the results of ABR measurements compared to awake mice but it has less influence on www.nature.com/scientificreports www.nature.com/scientificreports/ the results than other commonly used anaesthetics (e.g. isoflurane) 71, 72 . Body mass based calculation of anaesthetics and the same experimental protocol used for ABR measurements provided equal level of anaesthesia for all animals excluding its deteriorating effect on the KO vs. WT comparisons. During the ABR measurement, the body temperature was maintained and corneal drying was prevented. ABRs were recorded by an ABR System 3 workstation (Tucker-Davis Technologies, Alachua, FL). Click (0.4 ms duration) and tone burst (3 ms duration, 0.2 ms rise/decay; 4. 1, 8.2, 16 .4, 32.8 and 65.6 kHz) stimuli were generated by the SigGen software package and delivered in a closed acoustic system to the external auditory meatus through a plastic tube connected to an EC1 electrostatic speaker. Electroencephalograms were recorded with subdermal needle electrodes (Rochester www.nature.com/scientificreports www.nature.com/scientificreports/ Electro-medical Inc., USA) as the potential difference between an electrode on the vertex (active) and an electrode behind the right pinna (reference). The rear leg served as a ground. Measurements were always performed on the right ear. The evoked responses were amplified, and 800 sweeps were averaged in real time. The intensity was increased in 10 dB steps from 0 to 80 dB in click stimulation mode. To obtain auditory thresholds at different frequencies, the sound intensity of the tone burst stimuli was attenuated in 10 dB steps from 90 to 10 dB. The threshold was defined as the lowest intensity at which a visible ABR wave was seen (BioSig software) ( Fig. 1/a) . Numbers of measurements: 29 WT and 26 KO mice at the age of 1.5 month, 18 WT and 15 KO mice at the age of 4 months and 17 WT and 8 KO mice at the age of 8 months.
Besides measuring the hearing thresholds, we analysed the individual ABR waves evoked by tone burst stimuli in a Firebird based custom database in all of the 1.5-month-old mice (n = 29 WT and 26 KO). We identified the ABR peaks (peak I to peak V) and measured the amplitudes and latencies for each peak on each measured SPL. Peak latencies were determined relative to the onset of the acoustic stimuli and wave amplitudes were calculated as the difference between the two values represented by response maxima (peak) and subsequent minima (valley) (Figs 2/b, 3/b).
Auditory pathway activation -c-Fos immunolabeling.
We performed c-Fos immunolabeling for elucidating neuronal activation after white noise application in 1.5-month-old mice (n = 9 WT and 8 KO) in the following nuclei of the auditory pathway: VCN, DCN, SOC, NLL, IC and AU1 73 . We placed our mice into a closed ventilated "noise box". Noise exposure (4 to 20 kHz white noise with 100 dB sound pressure, 30 min) was generated with the Audacity computer software (Dominic Mazzoni, GNU GPL license) and an amplifier (Mc. Taatoo, Nightline Pro 400) connected to the PC. The piezo high frequency speaker was located on the ceiling of the box. The overall noise level and frequency composition were measured using a calibrated microphone in a combination with SVAN971 (SVANTEK SP. Z O.O.) sound level meter. After noise exposure, we allowed 1 hour for c-Fos transcription, translation and for its subsequent translocation to the nucleus. In contrast to the noise exposed group (labelled as 'noise'), the control group (labelled as 'silent') was held in a silent environment for 24 hours before termination including a 30 min period in the "noise box" without noise exposure.
Animals were overanesthetized with double-dose intraperitoneal ketamine-xylazine injection. Transcardial perfusion was performed by PBS solution (sodium phosphate-buffered saline, 20 ml, 0.1 M, pH 7.4), followed by paraformaldehyde fixative (150 ml 4% paraformaldehyde in 0.2 M Millonig sodium phosphate buffer, pH 7.4). After decapitation, the dissected brains were postfixed in the same fixative for 24 h, then 30 µm coronal sections were prepared using a Leica VT1000S vibratome (Leica Biosystems, Wetzlar, Germany). We performed free-floating immunohistochemistry with polyclonal rabbit anti-c-Fos antiserum (Santa Cruz Biotechnology Inc., sc-52, Santa Cruz, CA, USA, 1:500) followed by biotinylated goat anti-rabbit secondary antibody (Vectastain Elite ABC Kit, Vector Laboratories, Burlingame, CA, USA, 1:200) 27 . For visualization diaminobenzidine (DAB, D5637, Sigma-Aldrich, Hungary) was used. For detailed protocol please see Supplementary Information. For evaluation, Supplementary Table S2 for identification of all measured proteins. (c,d) Pixel density of protein dots acquired from cochlear duct lysates. There were no significant differences in either examined factors between wild-type (WT) and PACAPdeficient (KO) mice. Mean ± SEM, Student's t-test.
